Living With Sickle Cell Disease in the COVID-19 Pandemic

Clinical trial NCT04417673 · COMPLETED

Trial details

NCT number: NCT04417673
Sponsor: National Human Genome Research Institute (NHGRI)
Status: COMPLETED
Study type: OBSERVATIONAL

Isolation Anxiety Health Care Utilization Sickle Cell Disease Pain

Start date: 2020-06-15
Primary completion: 2022-05-18
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.